Home Tags Drug Development

Tag: Drug Development

SOTIO and LegoChem Biosciences Sign Exclusive Collaboration and License Agreement

ADC Review | Editorial Team
Clinical stage immuno-oncology company SOTIO Biotech and LegoChem Biosciences (LCB), a biotechnology company focused on developing its clinical-stage platform technology to develop antibody-drug conjugates...

Eric Rosenthal Reports: Why Academia Wasn’t Ready to Build Big Data...

ADC Review | Editorial Team
Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion. Roche...

New Lonza Facility Focuses on Formulation Development, Drug Product Analytical Development...

Peter Hofland
Earlier this year, Lonza, a global leader in chemical and biological manufacturing, held the grand opening of its new state-of-the-art pharmaceutical Drug Product Services...

OXIS’ Immunotherapeutic Development Strategy

Shaun Mehr
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc. discussed during its March 31, 2015 conference call with shareholders, analysts and other...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X